Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs

被引:0
|
作者
Urakami, Y [1 ]
Okuda, M [1 ]
Masuda, S [1 ]
Saito, H [1 ]
Inui, KI [1 ]
机构
[1] Kyoto Univ Hosp, Dept Pharm, Fac Med, Sakyo Ku, Kyoto 6068507, Japan
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have isolated a kidney-specific organic cation transporter, rat OCT2, which is distinct from rat OCT1 (Okuda M, Saito H, Urakami Y, Takano M and Inui K (1996) Biochem Biophys Res Commun 224:500-507). In our study, the functional characteristics and membrane localization of OCT1 and OCT2 were investigated by uptake studies using MDCK cells transfected with rat OCT1 or OCT2 cDNA (MDCK-OCT1 or MDCK-OCT2) and immunological studies. Tetraethylammonium (TEA) uptake by both MDCK-OCT1 and MDCK-OCT2 cells was markedly elevated when TEA was added to the basolateral medium, but not to the apical medium. Efflux of TEA from MDCK-OCT1 and MDCK-OCT2 cells was not changed by extracellular pH from 5.4 to 8.4, whereas TEA uptake by both transfectants was decreased by acidification of extracellular medium. Apparent K-m values for TEA uptake by MDCK-OCT1 and MDCK-OCT2 cells were 38 and 45 mu M, respectively. Although various hydrophilic organic cations such as 1-methyl-4-phenylpyridinium, cimetidine, quinidine, nicotine, N-1-methylnicotinamide and guanidine markedly inhibited TEA uptake by both MDCK-OCT1 and MDCK-OCT2 cells, there were no significant differences in the apparent inhibition constants [K-i] against these organic cations between both transfectants. Furthermore, immunological studies using a polyclonal antibody against OCT1 revealed that OCT1 was expressed in the basolateral membranes but not in the brush-border membranes of the rat kidney. These results suggested that both OCT1 and OCT2 are basolateral-type organic cation transporters with broad substrate specificities, mediating tubular secretion of cationic drugs.
引用
收藏
页码:800 / 805
页数:6
相关论文
共 50 条
  • [41] Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus: a systematic review protocol
    Edith Pascale Mofo Mato
    Magellan Guewo-Fokeng
    M. Faadiel Essop
    Peter Mark Oroma Owira
    Systematic Reviews, 7
  • [42] Multispecific Organic Cation Transporter 1 (OCT1) from Bos taurus Has High Affinity and Slow Binding Kinetics towards Prostaglandin E2
    He, Xiao
    Garza, Denisse
    Nigam, Sanjay K.
    Chang, Geoffrey
    PLOS ONE, 2016, 11 (04):
  • [43] Organic Cation Transporter 1 (OCT1/mOct1) Is Localized in the Apical Membrane of Caco-2 Cell Monolayers and Enterocytes
    Han, Tianxiang
    Everett, Ruth S.
    Proctor, William R.
    Ng, Chee M.
    Costales, Chester L.
    Brouwer, Kim L. R.
    Thakker, Dhiren R.
    MOLECULAR PHARMACOLOGY, 2013, 84 (02) : 182 - 189
  • [44] Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule
    Lee, Wing-Kee
    Reichold, Markus
    Edemir, Bayram
    Ciarimboli, Giuliano
    Warth, Richard
    Koepsell, Hermann
    Thevenod, Frank
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2009, 296 (06) : F1504 - F1513
  • [45] Nitric oxide down-regulates the expression of organic cation transporters (OCT) 1 and 2 in rat kidney during endotoxemia
    Heemskerk, Suzanne
    Wouterse, Alforts C.
    Russel, Frans G. M.
    Masereeuw, Rosalinde
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 584 (2-3) : 390 - 397
  • [46] The organic cation transporter OCT2 mediates the uptake of β-adrenoceptor antagonists across the apical membrane of renal LLC-PK1 cell monolayers
    Dudley, AJ
    Bleasby, K
    Brown, CDA
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (01) : 71 - 79
  • [47] COMPARE INHIBITION EFFECT OF CERTAIN DRUGS TO HUMAN ORGANIC CATION TRANSPORTER 2 (OCT2) AND MULTIDRUG AND TOXIN EXTRUSION TRANSPORTER 1 (MATE1) IN STABLE CELL LINES
    Guo, Dong
    Li, Qing
    Yang, Hong
    Yan, Shu
    DRUG METABOLISM REVIEWS, 2015, 47 : 294 - 294
  • [48] IN VITRO-IN VIVO CORRELATION (IVIVC) OF DRUG INDUCED INHIBITION OF CREATININE TUBULAR SECRETION USING MDCK CELLS EXPRESSING OCT2/OAT2/OCT3/MATE1/MATE2K TRANSPORTERS.
    Zhang, X.
    Jiang, W.
    Li, C.
    Huang, J.
    Huang, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S60 - S60
  • [49] Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1)
    Joachim Strobel
    Fabian Müller
    Oliver Zolk
    Beate Endreß
    Jörg König
    Martin F. Fromm
    Renke Maas
    Amino Acids, 2013, 45 : 989 - 1002
  • [50] Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1)
    Strobel, Joachim
    Mueller, Fabian
    Zolk, Oliver
    Endress, Beate
    Koenig, Joerg
    Fromm, Martin F.
    Maas, Renke
    AMINO ACIDS, 2013, 45 (04) : 989 - 1002